Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5
The MONITOR-CKD5 trial evaluating anemia treatment, outcomes, and determinants in chronic kidney disease stage 5 (end-stage renal disease) h…
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Hemodialysis Frequency and the Calcification Propensity of Serum [NA]
Clinical trial update on how hemodialysis frequency may influence the calcification propensity of serum in patients undergoing dialysis.
-
CLINICAL_TRIALS research · 2016-04-06Clinical Trial Update: The Effect of Steroid Pulse Therapy for the Reduction of Acute Rejection Episode in Subclinical Borderline Changes [NA]
This document provides an update on a clinical trial evaluating whether steroid pulse therapy reduces acute rejection in subclinical borderl…
-
CLINICAL_TRIALS trial_result · 2016-04-01Clinical Trial Update: A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease. [Phase 3]
A Phase 3 study of subcutaneous Mircera for anemia in pre-dialysis chronic kidney disease participants was terminated, and results were post…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: The Analysis of Correlation About the Spot Urine Sodium and the Blood Pressure in General Population According to the Income Level
Completed observational analysis examining the relationship between spot urine sodium and blood pressure across income levels in the general…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis
An observational study evaluating Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as maintenance therapy for chronic renal anemia in pati…
-
CLINICAL_TRIALS research · 2016-03-25Clinical Trial Update: An Observational, Cross Sectional Study to Assess the Prevalence of Chronic Kidney Disease (CKD) in Type 2 Diabetes Patients
An observational cross-sectional study sponsored by AstraZeneca assessed how common chronic kidney disease is among patients with type 2 dia…
-
FDA approval · 2016-03-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approves a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V., describing its…
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study) [Phase 3]
Phase IIIb study evaluating the safety and efficacy of gemigliptin in adults with Type 2 diabetes mellitus and moderate-to-severe renal impa…
-
CLINICAL_TRIALS research · 2016-03-17Clinical Trial Update: Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra) [Phase 2]
Phase 2 clinical trial investigating the role of genetics and interleukin-1 receptor antagonist (IL-1ra) in inflammation associated with chr…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: RAS Quantification in Patients With Aliskiren or Candesartan [Phase 4]
Phase 4 clinical trial update assessing renin-angiotensin system quantification in patients with hypertension or chronic kidney disease trea…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia [Phase 2]
A Phase 2 study assessing fixed dosing of AMG 223 in adults with chronic kidney disease on hemodialysis has completed.
-
FDA approval · 2016-03-09FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Sevelamer Hydrochloride submitted by Sanofi-Aventis U.S. LLC. This action constitutes a supp…
-
FDA approval · 2016-03-09FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer carbonate from Sanofi-Aventis U.S. LLC.
-
FDA approval · 2016-03-09FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for sevelamer carbonate, resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
An observational study assessing correction of anemia with monthly darbepoetin alfa in patients with chronic kidney disease not on dialysis.…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: NAG-excretion During Cardiopulmonary Bypass
A clinical trial evaluating urinary N-acetyl-β-D-glucosaminidase (NAG) excretion during cardiopulmonary bypass has completed.
-
FDA approval · 2016-03-02FDA Approved: VENOFER — Supplemental Application (Fresenius Medical Care Holdings, Inc.)
The FDA approved a supplemental application for VENOFER (iron sucrose) submitted by Fresenius Medical Care Holdings, Inc., resulting in chan…
-
FDA approval · 2016-02-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, Inc., updating/expanding the product’s approv…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Valsartan in Cardiovascular Disease With Renal Dysfunction (The V-CARD) Study [Phase 4]
Phase 4 trial of valsartan for hypertension with renal dysfunction (V-CARD) has been terminated.
-
FDA approval · 2016-02-24FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-02-24FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Hemodialysis Vascular Access Imaging Study
A completed clinical trial update evaluating imaging of hemodialysis vascular access (fistula) sponsored by the Renal Research Institute.
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Body Fluid Dynamics in Hemodialysis Patients, an Estimation of Dry Weight
This clinical trial on body fluid dynamics and dry weight estimation in hemodialysis patients has been terminated.
-
CLINICAL_TRIALS withdrawal · 2016-02-24Clinical Trial Update: Red Blood Cell Lifespan
A clinical trial studying red blood cell lifespan in chronic kidney disease and patients on hemodialysis has been terminated.